EUVIMED · CrossrefZeitschrift
Hepatobiliary & Pancreatic Diseases International
ISSN 1499-3872 · Elsevier BV
Neueste Artikel
Breaking barriers: HepCAT drives multi-dimensional transcriptomic data analysis and precision medicine in hepatocellular carcinoma
Triglyceride-glucose index is prognostic biomarker for all-cause mortality in patients with acute-on-chronic liver failure
Association between close margin status and survival in the modern systemic treatment era for pancreatic ductal adenocarcinoma
Aspirin reduces intrahepatic recurrence of hepatocellular carcinoma after liver transplantation
New autologous tissue coverage technique: Transverse mesocolon isolation in middle pancreatectomy (with video)
Psoas muscle index as a prognostic indicator in acute cholangitis
Stratification of adjuvant FOLFOX chemotherapy after liver transplantation for hepatocellular carcinoma
Targeting the macrophage sirtuin 3-isocitrate dehydrogenase 2 axis to mitigate ischemia-reperfusion injury in aged donor livers
Transjugular intrahepatic portosystemic shunt alleviated Gynura japonica-induced sinusoidal obstruction syndrome with refractory hepatorenal syndrome
Optimizing AI-assisted biliary stent selection: The geometric challenge of the internal reference marker
Targeted and immunotherapy strategies in pancreatic ductal adenocarcinoma: Recent developments and insights
Multiphase enhanced computed tomography features captured by delta radiomics reveal prognosis and tumor heterogeneity in patients with hepatocellular carcinoma treated with transarterial chemoembolization
Transfer RNA-derived small RNAs in liver disease
Antibody-drug conjugates specifically regulate tumor microenvironment: A promising strategy for pancreatic cancer treatment
Timing of endoscopic retrograde cholangiopancreatography in acute cholangitis: A cohort study in Colombia
Bile acids as gatekeepers: Orchestrating gut-liver axis for metabolic and immune balance
YBX1 is required for maintaining PD-L1 expression in intrahepatic cholangiocarcinoma by regulating STAT1 stability in an m5C-dependent manner
Efficacy of regorafenib following first-line immune checkpoint inhibitor failure in patients with advanced hepatocellular carcinoma: A multicenter study
Sarcopenia is risk factor for prognosis of patients with biliopancreatic diseases
Chronic hepatitis E: The neglected liver killer
Body composition predicts prognosis of patients with hepatocellular carcinoma after liver transplantation: A multicenter study
Microbiota-related metabolites correlated with the severity of COVID-19 patients
The outcomes and mechanisms of chronic hepatitis B complicated by metabolic dysfunction-associated steatotic liver disease
Adjuvant chemotherapy improves post-transplant outcome in patients with hepatocellular carcinoma
Early prediction of mortality in acute cholangitis: Elaboration of a new simple prognostic score
Baicalin and its nanoliposome ameliorate diquat-induced liver injury by promoting PINK1/Parkin-dependent mitophagy
Sodium butyrate ameliorates liver fibrosis in metabolic dysfunction-associated steatohepatitis rats via miR-155-5p/SOCS1/PDGF signaling pathway
Nomogram for prediction of hepatocellular carcinoma recurrence after liver resection
Adjuvant lenvatinib in combination with transarterial chemoembolization for hepatocellular carcinoma patients with high risk of postoperative recurrence: A multicenter prospective cohort study
Cisplatin induces acute liver injury by triggering caspase-3/GSDME-mediated cell pyroptosis
EUVIMED